Coherent Corp director exercises options, sells 2,000 COHR shares

Coherent Corp. director reports option exercise and share sales.

Accepted by SEC EDGAR 12/03/2025 - 05:06 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Coherent Corp. director reports option exercise and share sales. A director of Coherent Corp. (COHR) exercised an option to acquire 2,000 shares of common stock at an exercise price of $21.67 per share on 12/02/2025. On the same date, the director reported selling 1,000 shares at $168 per share and another 1,000 shares at $172 per share.

Following these transactions, the director reported owning 50,019 shares of common stock directly. The filing also shows an option (right to buy) covering 2,000 underlying shares with an exercise price of $21.67 and an expiration date of 08/20/2026, with 6,240 derivative securities beneficially owned after the reported activity. The option originally vested in four equal annual installments beginning on 08/17/2017.

Insider Trade Summary

Exercise and Sale: 2,000 shares ($297K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Xia Howard H.

Role Director

Sold 2,000 shs ($340K)

Approx. gross sale proceeds $340K

Approx. exercise cost $43K

Approx. pre-tax spread $297K

Share of Position Sold 3.8%

Type	Security	Shares	Price	Value
Exercise	Option (Right to Buy)	2,000	$0.00	$0.00
Exercise	Common Stock	2,000	$21.67	$43K
Sale	Common Stock	1,000	$168.00	$168K
Sale	Common Stock	1,000	$172.00	$172K

Holdings After Transaction: Option (Right to Buy) — 6,240 contracts (Direct); Common Stock — 50,019 shares (Direct)

Holdings Before and After: Option (Right to Buy), 8,240 to 6,240 contracts (Direct); Common Stock, 50,019 to 50,019 shares (Direct)

Other Insiders: 8 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. This option vested in four equal annual installments beginning on August 17, 2017.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Coherent Corp. (COHR) report in this Form 4?

The Form 4 reports that a director of Coherent Corp. exercised an option to acquire 2,000 shares of common stock at an exercise price of $21.67 per share on 12/02/2025, and on the same date sold 1,000 shares at $168 per share and another 1,000 shares at $172 per share.

How many Coherent Corp. (COHR) shares does the reporting person own after the transaction?

After the reported transactions, the director beneficially owns 50,019 shares of Coherent Corp. common stock directly, as disclosed in the filing.

What options or derivative securities related to COHR does the insider still hold?

The filing lists an option (right to buy) with an exercise price of $21.67 per share, covering 2,000 underlying shares of common stock, with an expiration date of 08/20/2026. After the transactions, the reporting person beneficially owns 6,240 derivative securities.

When did the reported Coherent Corp. (COHR) insider transactions occur?

The option exercise and the two stock sale transactions all occurred on 12/02/2025, as shown in both the non-derivative and derivative security tables.

How did the director’s stock option in Coherent Corp. vest?

According to the explanation of responses, the stock option vested in four equal annual installments beginning on 08/17/2017.

What roles does the reporting person have at Coherent Corp. (COHR)?

The reporting person is identified as a director of Coherent Corp. on the form, with the box for director checked and no officer title indicated.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Xia Howard H.

(Last) (First) (Middle)

C/O COHERENT CORP.

375 SAXONBURG BOULEVARD

(Street)

SAXONBURG PA 16056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COHERENT CORP. [ COHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/02/2025		M		2,000	A	$21.67	52,019	D
Common Stock	12/02/2025		S		1,000	D	$168	51,019	D
Common Stock	12/02/2025		S		1,000	D	$172	50,019	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$21.67	12/02/2025		M			2,000	(1)	08/20/2026	Common Stock	2,000	$0.00	6,240	D

Explanation of Responses:

1. This option vested in four equal annual installments beginning on August 17, 2017.

	/s/ Christopher M. Forrester, Attorney-in-Fact	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.